1 Incretin-Based Drugs Market Overview
1.1 Product Overview and Scope of Incretin-Based Drugs
1.2 Incretin-Based Drugs Segment by Type
1.2.1 Global Incretin-Based Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.2.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.3 Incretin-Based Drugs Segment by Application
1.3.1 Global Incretin-Based Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Oral Drugs
1.3.3 Injectable Drugs
1.4 Global Incretin-Based Drugs Market Size Estimates and Forecasts
1.4.1 Global Incretin-Based Drugs Revenue 2017-2028
1.4.2 Global Incretin-Based Drugs Sales 2017-2028
1.4.3 Incretin-Based Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Incretin-Based Drugs Market Competition by Manufacturers
2.1 Global Incretin-Based Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Incretin-Based Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Incretin-Based Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Incretin-Based Drugs Manufacturing Sites, Area Served, Product Type
2.5 Incretin-Based Drugs Market Competitive Situation and Trends
2.5.1 Incretin-Based Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Incretin-Based Drugs Players Market Share by Revenue
2.5.3 Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Incretin-Based Drugs Retrospective Market Scenario by Region
3.1 Global Incretin-Based Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Incretin-Based Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Incretin-Based Drugs Market Facts & Figures by Country
3.3.1 North America Incretin-Based Drugs Sales by Country
3.3.2 North America Incretin-Based Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Incretin-Based Drugs Market Facts & Figures by Country
3.4.1 Europe Incretin-Based Drugs Sales by Country
3.4.2 Europe Incretin-Based Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Incretin-Based Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Incretin-Based Drugs Sales by Region
3.5.2 Asia Pacific Incretin-Based Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Incretin-Based Drugs Market Facts & Figures by Country
3.6.1 Latin America Incretin-Based Drugs Sales by Country
3.6.2 Latin America Incretin-Based Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Incretin-Based Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Incretin-Based Drugs Sales by Country
3.7.2 Middle East and Africa Incretin-Based Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Incretin-Based Drugs Historic Market Analysis by Type
4.1 Global Incretin-Based Drugs Sales Market Share by Type (2017-2022)
4.2 Global Incretin-Based Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Incretin-Based Drugs Price by Type (2017-2022)
5 Global Incretin-Based Drugs Historic Market Analysis by Application
5.1 Global Incretin-Based Drugs Sales Market Share by Application (2017-2022)
5.2 Global Incretin-Based Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Incretin-Based Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GlaxoSmithKline Incretin-Based Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Johnson & Johnson Incretin-Based Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck & Co
6.3.1 Merck & Co Corporation Information
6.3.2 Merck & Co Description and Business Overview
6.3.3 Merck & Co Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Merck & Co Incretin-Based Drugs Product Portfolio
6.3.5 Merck & Co Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AstraZeneca Incretin-Based Drugs Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Novartis Incretin-Based Drugs Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Corporation Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Eli Lilly and Company Incretin-Based Drugs Product Portfolio
6.6.5 Eli Lilly and Company Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boehringer Ingelheim Incretin-Based Drugs Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Takeda Pharmaceutical Company
6.8.1 Takeda Pharmaceutical Company Corporation Information
6.8.2 Takeda Pharmaceutical Company Description and Business Overview
6.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Takeda Pharmaceutical Company Incretin-Based Drugs Product Portfolio
6.8.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Incretin-Based Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi Incretin-Based Drugs Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Incretin-Based Drugs Manufacturing Cost Analysis
7.1 Incretin-Based Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Incretin-Based Drugs
7.4 Incretin-Based Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Incretin-Based Drugs Distributors List
8.3 Incretin-Based Drugs Customers
9 Incretin-Based Drugs Market Dynamics
9.1 Incretin-Based Drugs Industry Trends
9.2 Incretin-Based Drugs Market Drivers
9.3 Incretin-Based Drugs Market Challenges
9.4 Incretin-Based Drugs Market Restraints
10 Global Market Forecast
10.1 Incretin-Based Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Incretin-Based Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Incretin-Based Drugs by Type (2023-2028)
10.2 Incretin-Based Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Incretin-Based Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Incretin-Based Drugs by Application (2023-2028)
10.3 Incretin-Based Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Incretin-Based Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Incretin-Based Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
